Media coverage about IntriCon (NASDAQ:IIN) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. IntriCon earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned news stories about the technology company an impact score of 44.3886966925826 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
A number of analysts have recently commented on the stock. Zacks Investment Research cut shares of IntriCon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th. Longbow Research restated a “neutral” rating on shares of IntriCon in a report on Friday, August 25th. Finally, TheStreet upgraded shares of IntriCon from a “c” rating to a “b-” rating in a report on Wednesday, November 8th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. IntriCon currently has a consensus rating of “Hold” and a consensus target price of $10.25.
Shares of IntriCon (IIN) opened at $20.10 on Wednesday. IntriCon has a fifty-two week low of $6.05 and a fifty-two week high of $20.20. The company has a market cap of $131.54, a price-to-earnings ratio of 212.78, a PEG ratio of 3.68 and a beta of 0.34. The company has a current ratio of 1.45, a quick ratio of 0.54 and a debt-to-equity ratio of 0.34.
IntriCon Company Profile
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.